Stay updated on Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 added; the notice about government funding lapse and operating status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedSite-wide notice about a lapse in government funding and an update to the page revision (v3.4.1), replacing the previous v3.4.0 reference.SummaryDifference0.4%

- Check28 days agoChange DetectedShow glossary toggle was added to the page and new metadata fields Last Update Submitted that Met QC Criteria and Last Update Posted were introduced. Minor wording changes were made to No FEAR Act data and the revision note (Revision: v3.4.0).SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 on the page.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a Locations section with Texas as a location. Removed the Texas Locations entry and the HHS Vulnerability Disclosure; updated revision from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedThe Publications section now notes that PubMed publications are automatically filled and may not be about the study, and a new revision tag v3.3.2 was added (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.